No abstract available
Publication types
-
Case Reports
-
Letter
-
Review
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / therapeutic use*
-
Child, Preschool
-
Humans
-
Male
-
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
daratumumab
Associated data
-
ClinicalTrials.gov/NCT03384654